PCVX FY 2020 Earnings — Vaxcyte, Inc. Revenue & Financial Results | Market Cap Arena

PCVXVaxcyte, Inc.

$9B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$90M

Net Income

-$89M

EPS (Diluted)

$-2.97

Cash Flow

Operating Cash Flow

-$47M

Free Cash Flow

-$48M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$393M

Total Liabilities

$47M

Stockholders' Equity

$346M

Cash & Equivalents

$386M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$1M	-14.0%
Operating Income	-$90M	-$54M	-65.4%
Net Income	-$89M	-$50M	-77.5%